These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36678796)

  • 1. Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects.
    Abdelhamid MAA; Ki MR; Abd El-Hafeez AA; Son RG; Pack SP
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress of Rational Modified Nanocarriers for Cytosolic Protein Delivery.
    He X; Xiong S; Sun Y; Zhong M; Xiao N; Zhou Z; Wang T; Tang Y; Xie J
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
    Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
    Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recent advancements in protein nanoparticles for immunotherapy.
    Xu M; Wei S; Duan L; Ji Y; Han X; Sun Q; Weng L
    Nanoscale; 2024 Jun; 16(25):11825-11848. PubMed ID: 38814163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy.
    Seidu TA; Kutoka PT; Asante DO; Farooq MA; Alolga RN; Bo W
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
    Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
    Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer.
    Ebrahimnejad P; Sodagar Taleghani A; Asare-Addo K; Nokhodchi A
    Drug Discov Today; 2022 Feb; 27(2):471-489. PubMed ID: 34781032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
    Katopodi T; Petanidis S; Tsavlis D; Anestakis D; Charalampidis C; Chatziprodromidou I; Eskitzis P; Zarogoulidis P; Kosmidis C; Matthaios D; Porpodis K
    Front Oncol; 2022; 12():1042125. PubMed ID: 36338748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in active targeting of nanomaterials for anticancer drug delivery.
    Dutta B; Barick KC; Hassan PA
    Adv Colloid Interface Sci; 2021 Oct; 296():102509. PubMed ID: 34455211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Biomedical Approaches for Chitosan Based Materials as Drug Delivery Nanocarriers.
    Iacob AT; Lupascu FG; Apotrosoaei M; Vasincu IM; Tauser RG; Lupascu D; Giusca SE; Caruntu ID; Profire L
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications.
    Hu QD; Tang GP; Chu PK
    Acc Chem Res; 2014 Jul; 47(7):2017-25. PubMed ID: 24873201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.